JOINT FILING AGREEMENT
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of CAMP4 Therapeutics Corporation shall be filed on behalf of each of the undersigned and that this Joint Filing Agreement shall be filed as an exhibit to such Schedule 13D.
Dated: September 11, 2025
5AM Ventures VI, L.P. By: 5AM Partners VI, LLC its General Partner By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member | 5AM Partners VI, LLC By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member |
5AM Ventures VII, L.P. By: 5AM Partners VII, LLC its General Partner By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member | 5AM Partners VII, LLC By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member |
5AM Opportunities II, L.P. By: 5AM Opportunities II (GP), LLC its General Partner By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member | 5AM Opportunities II (GP), LLC By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member |
/s/ Andrew J. Schwab
Andrew J. Schwab /s/ Dr. Kush Parmar Dr. Kush Parmar |